poisar

Stocks · News reference

Apimeds’ Subsidiary MindWave Signs 12-Month Software Development And Technology Services Agreement With Flash Sports & Media To Build And Operate FlashChain

Benzinga Newsdesk

MindWave Innovations Inc. ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE:APUS), has signed a 12-month software development and technology services agreement with New York-based

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

APUS
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Ibn

    MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure

    MindWave Innovations Inc. USA, a subsidiary of Apimeds Pharmaceuticals US, Inc., signed three blockchain network agreements within 10 days with AQUAE Holdings (climate finance), Flash Sports & Media Holdings (sports media), and BlockAssure Inc. (insurance). Each agreement follows the same model where MindWave builds and operates dedicated MindChain networks while receiving 20% token/credit allocations. However, the parent company disclosed substantial doubt about its ability to continue as a going concern.

    APUSFLZH